Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.16
BATS BZX Real-Time Price
As of 3:12pm ET
 +0.01 / +0.10%
Today’s Change
6.38
Today|||52-Week Range
13.84
-10.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash--37.8M65.2M35.8M
 
 
 
 
Short Term Investment Cash19.7M-12.7M27.4M-29.4M
 
 
 
 
 
Cash & Short Term Investments50.5M110.1M155.3M124.1M
 
 
 
 
 
 
ReceivablesReceivables7.4M9.3M5.9M3.3M
 
 
 
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsPrepaid Expenses1.9M------
 
 
Other Current Assets5.8M9.0M5.5M4.7M
 
 
 
 
 
Current Assets65.6M128.3M166.6M132.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross22.3M25.3M34.9M38.6M
 
 
 
 
 
Depreciation-16.1M-19.0M-21.5M-24.1M
 
 
 
 
 
Intangible Assets13.1M12.8M11.7M11.3M
 
 
 
 
 
Other Assets13.1M13.9M11.8M11.5M
 
 
 
 
 
Total Assets85.3M149.0M192.4M158.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.7M283.0K1.9M2.5M
 
 
 
 
 
Short Term Debt48.0K2.4M8.2M13.3M
 
 
 
 
 
Accrued Expenses9.2M17.9M29.0M28.1M
 
 
 
 
 
Other Current Liabilities17.0M30.0M40.3M88.6M
 
 
 
 
 
Other Liabilities26.2M38.5M57.7M111.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.0037.5M103.4M106.8M
 
 
 
 
Deferred Taxes-1.3M0.00-507.0K-496.0K
 
 
 
 
Other Liabilities1.5M2.0M1.2M1.2M
 
 
 
 
 
Total Liabilities107.0M155.4M235.5M260.7M
 
 
 
 
 
 
EquityMinority Interest-453.0K-477.0K-240.0K-268.0K
 
 
 
 
 
Preferred Stock268.2M0.000.000.00
 
 
Common Equity-290.5M-6.5M-43.5M-102.1M
 
 
 
 
 
Total Shareholder Equity-22.3M-6.5M-43.5M-102.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding11.8M95.8M102.5M106.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.